TA-65 and Aging Associated Microvascular Dysfunction
The goal of this clinical trial is to test whether activation of telomerase with a dietary supplement (TA-65) improves microvascular function.
Healthy Adults 18 - 35 and 65+ years of age [+1]
36-64 years of age without clinical diagnosis of CAD [+23]